FDA advisory committee recommends banning OTC codeine sold to children
The FDA’s Pulmonary-Allergy Drugs Advisory Committee voted to ban codeine-combination medication sold over-the-counter and to contraindicate the medication for children aged younger than 18 years as both a painkiller and as cough medicine.
See this content immediately after install